Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CSX | CAT |
|---|---|---|
| Price | $46.91 | $805.07 |
| Change today | ▼ 0.59% | ▼ 0.86% |
| Market cap | $86.90B | $370.07B |
| Return, 3 months | +2.1% | -18.9% |
| Return, year to date | +30.6% | +41.4% |
| Return, 1 year | +40.5% | +72.9% |
| P/E (TTM) | 27.1 | 34.7 |
| P/B | 6.2 | 19.1 |
| P/E percentile vs own 5y | 91st | 89th |
| Dividend yield | 1.15% | 0.75% |
| Revenue growth (YoY, latest qtr) | +10.1% | +24.0% |
| Net profit growth (YoY) | +20.9% | +64.9% |
| Gross margin | 35.3% | 32.5% |
| Operating margin | 35.5% | 17.5% |
| Net margin | 22.2% | 14.5% |
| Return on equity | 24.4% | 57.0% |
| Analyst target vs. price | +15.0% | +25.5% |
| Analyst buy share | 74% | 47% |
| RSI (14) | 37 | 47 |
| 30-day volatility | 18.1% | 29.3% |
| Max drawdown, 1 year | -13.4% | -26.7% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.